These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15725052)
21. COPD inhaler selection--factors to consider. Straw A; Heins JR; Evers M S D Med; 2015 May; 68(5):217-9. PubMed ID: 26058261 [No Abstract] [Full Text] [Related]
22. Advances in Audio-Based Systems to Monitor Patient Adherence and Inhaler Drug Delivery. Taylor TE; Zigel Y; De Looze C; Sulaiman I; Costello RW; Reilly RB Chest; 2018 Mar; 153(3):710-722. PubMed ID: 28887061 [TBL] [Abstract][Full Text] [Related]
23. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research. Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842 [TBL] [Abstract][Full Text] [Related]
24. The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers. Weers J; Clark A Pharm Res; 2017 Mar; 34(3):507-528. PubMed ID: 27738953 [TBL] [Abstract][Full Text] [Related]
25. The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device. Perriello EA; Sobieraj DM Conn Med; 2016; 80(6):359-64. PubMed ID: 27509644 [TBL] [Abstract][Full Text] [Related]
26. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD]. Henriet AC; Marchand-Adam S; Mankikian J; Diot P Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393 [TBL] [Abstract][Full Text] [Related]
28. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers. Grant AC; Walker R; Hamilton M; Garrill K J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466 [TBL] [Abstract][Full Text] [Related]
30. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. Ding B; Small M; Scheffel G; Holmgren U Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581 [TBL] [Abstract][Full Text] [Related]
31. Novolizer: how does it fit into inhalation therapy? Magnussen H Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944 [TBL] [Abstract][Full Text] [Related]
32. Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD). Wright J; Brocklebank D; Ram F Qual Saf Health Care; 2002 Dec; 11(4):376-82. PubMed ID: 12468702 [TBL] [Abstract][Full Text] [Related]
33. The Ellipta Jones TL; Neville DM; Chauhan AJ Ther Deliv; 2018 Feb; 9(3):169-176. PubMed ID: 29424288 [TBL] [Abstract][Full Text] [Related]
35. Dry powder inhalers: which factors determine the frequency of handling errors? Wieshammer S; Dreyhaupt J Respiration; 2008; 75(1):18-25. PubMed ID: 17911976 [TBL] [Abstract][Full Text] [Related]
36. Use of dry powder inhalers in COPD. Wilson DS; Gillion MS; Rees PJ Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806 [TBL] [Abstract][Full Text] [Related]
37. [The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)]. Larsson K; Bjermer L; Svartengren M Lakartidningen; 2019 Feb; 116():. PubMed ID: 30720857 [TBL] [Abstract][Full Text] [Related]
38. Acceptance of the Accuhaler, a multi-dose powder inhaler, among asthmatic patients: a comparison with the pressurized metered-dose inhaler. Liam CK; Lim KH; Wong CM Asian Pac J Allergy Immunol; 2000 Sep; 18(3):135-40. PubMed ID: 11270467 [TBL] [Abstract][Full Text] [Related]
40. Device errors in asthma and COPD: systematic literature review and meta-analysis. Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]